glp-1 receptor agonist diarrhea management Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH GLP-1RA Essentials in Gastroenterology: Side
Description
Front Endocrinol 2018

Incorrect peptide content means actual dosing may be much higher or lower than intended, which directly affects both efficacy and side effect risk

Liraglutide is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist

Xu D, Nair A, Sigston C, et al

The categorical distinction: Dietary supplements do not contain pharmaceutical GLP-1 drugs